ABBVIE ACQUIRES BOTOX-MAKER ALLERGAN IN LANDMARK DEAL

摘要

AbbVie, the biopharmaceutical company, has acquired Allergan in what its CEO described as an "important milestone". The acquisition includes Allergan's global aesthetics business which comprises injectables brands Botox and Juvederm as well as CoolSculpting, which Allergan acquired in 2017. Calling the deal a 'turning point', Richard Gonzalez, Chairman and CEO of AbbVie, said: "We are pleased to reach this important milestone for the company, its employees, shareholders and the patients we serve."